81 related articles for article (PubMed ID: 6189143)
21. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
22. [Effect of postoperative chemotherapy on treatment effectiveness in breast cancer].
Bavli IaL
Vopr Onkol; 1980; 26(5):13-5. PubMed ID: 6770540
[TBL] [Abstract][Full Text] [Related]
23. [The combination of thio-tepa and 5 fluorouracil as a palliative therapy for breast cancer].
Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M
Rev Fr Gynecol Obstet; 1973 Mar; 68(3):159-65. PubMed ID: 17472211
[TBL] [Abstract][Full Text] [Related]
24. [Advanced carcinoma of the breast. Results of a polychemotherapeutic protocol].
Fazio M; Manca A; Rodino A; Cavallero P; Tripodina A
Minerva Ginecol; 1982 Sep; 34(9):667-70. PubMed ID: 7145204
[No Abstract] [Full Text] [Related]
25. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy for Chinese women with locally advanced breast cancer.
Chow LW; Day W; Ng KC
Am Surg; 2001 May; 67(5):412-6. PubMed ID: 11379638
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D; Gelman R; Falkson G
Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
[No Abstract] [Full Text] [Related]
28. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
Chang YC; Falkson G; Tormey DC; Crowley J
Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
[TBL] [Abstract][Full Text] [Related]
29. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
30. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
31. [Clinical study of preoperative chemotherapy of primary breast cancer. 1. Efficacy of a combined use of CPA (endoxan) and FT-207 (or 5-FU dry syrup)].
Komuro K; Hara Y; Fujii Y; Yamazaki M; Amano R; Hashiguchi F; Sakamoto R; Nakamura R; Shimada A; Kurata T; Ando H; Nakamura K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2180-5. PubMed ID: 6820892
[TBL] [Abstract][Full Text] [Related]
32. [High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative study].
Solano C; Sola C; Lluch A; Hornedo J; López J; Cortés-Funes H; García-Conde J
Sangre (Barc); 1997 Apr; 42 Suppl 1():53-6. PubMed ID: 9381304
[No Abstract] [Full Text] [Related]
33. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF
Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628
[TBL] [Abstract][Full Text] [Related]
34. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
[TBL] [Abstract][Full Text] [Related]
35. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Hofmann W; Langkopf B
Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
[No Abstract] [Full Text] [Related]
36. The leucocyte nadir, a predictor of chemotherapy efficacy?
Kvinnsland S
Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
[No Abstract] [Full Text] [Related]
37. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Zander AR; Krüger W; Kröger N; Damon L; Königmann M; Berdel WE; Gieseking F; Schäfer-Eckart K; Möbus V; Frickhofen N; Wandt H; Illiger HJ; Metzner B; Kolbe K; Wörmann B; Trümper L; Huber C; Hossfeld DK; Maass H; Jonat W
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S24-5. PubMed ID: 8899165
[No Abstract] [Full Text] [Related]
38. [Chemotherapy of advanced breast cancer--actual results ].
Matthes ML; Lenk H; Gürtler R; Tanneberger S
Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
[TBL] [Abstract][Full Text] [Related]
39. High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Antman K; Ayash L; Elias A; Wheeler C; Schwartz G; Mazanet R; Tepler I; Schnipper LE; Frei E
J Natl Cancer Inst Monogr; 1994; (16):91-4. PubMed ID: 7528031
[TBL] [Abstract][Full Text] [Related]
40. A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
Stewart DJ; Maroun JA; Hirte W; Perrault D; Stolbach L; Cripps C; Lefebvre B
Semin Oncol; 1984 Sep; 11(3 Suppl 1):23-7. PubMed ID: 6385261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
